🔎 Trials Near Me

Home › Frailty › NCT06960421

Exercise-based Frailty Intervention in Lung Transplantation (XFIT)

Recruiting

An eXercise-based Frailty Intervention in Lung Transplantation (XFIT): A Phase Ib Clinical Trial Focused on Establishing Safety

Who can join

Ages 18 to 75 · All sexes

Full eligibility criteria
Group 1

Inclusion Criteria:

* Age 18 - 65 years
* Lung Transplant Candidates
* Speaks English or Spanish
* ≤ 8LPM O2 on 6MWT
* SPPB score ≤ 10

Exclusion Criteria:

* Lives Alone
* BMI \< 18.0 kg/m2
* Engaged in clinical pulmonary rehabilitation program
* Severe pHTN (RHC mPAP ≥ 30 mmHg or TTE PASP ≥ 60mmHg or moderately/severely reduced RV systolic function on TTE
* Deemed unsafe by site PI

Group 2

Inclusion Criteria:

* Age 18 - 75 years
* Speaks English or Spanish
* ≤ 15LPM O2 on 6MWT
* SPPB score ≤ 10

Exclusion Criteria:

* Lives Alone
* BMI \< 18.0 kg/m2
* Engaged in clinical pulmonary rehabilitation program
* Severely reduced RV systolic function on TTE
* Deemed unsafe by site PI

About the study

The goal of XFIT study is to measure the safety of an 8-week telehealth-delivered exercise and behavioral training program to treat frailty in lung transplant candidates in their own home. The main questions XFIT aims to answer are:

* Is XFIT safe? * Is XFIT feasible and acceptable by participants? * Is XFIT effective in improving frailty and physical function as reflected in patient-reported outcomes.

Participants will:

\- Participate in the 8-week XFIT program or enhanced standard of care

What is being tested

Sponsor: University of California, San Francisco · Participants: 70 · Started: Oct 22, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT06960421

Locations in the U.S.

CaliforniaUniversity of California,San Francisco, San Francisco
New YorkColumbia University, New York (Not yet recruiting)
North CarolinaUniversity of North Carolina, Chapel Hill (Not yet recruiting)
PennsylvaniaUniversity of Pennsylvania, Philadelphia (Not yet recruiting)

Conditions

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.